#Japan #Tokyo #Medipal Holdings #MP Agro #Cygni Holdings

MP Agro Completes Acquisition of Cygni Holdings

In a significant move within the animal health industry, MP Agro Co., Ltd. announced the successful completion of its acquisition of Cygni Holdings, Inc. on January 30, 2026. This strategic decision comes on the heels of an initial disclosure made on October 9, 2025, highlighting MP Agro's intention to acquire 100% of Cygni Holdings.

Cygni Holdings, headquartered in Chuo-ku, Tokyo, serves as a consolidated subsidiary of MP Agro, which is based in Kitahiroshima, Hokkaido. The acquisition is expected to provide substantial growth opportunities in the e-commerce sector for companion animal products. Despite the acquisition, MP Agro has indicated that it does not foresee significant impact on its financial performance for the current fiscal period.

Leadership Structure Post-Acquisition

With the acquisition now complete, both Cygni Holdings and its subsidiary Cygni Co., Ltd. will retain their brand names. The leadership for Cygni Holdings as of January 30, 2026, includes:

• - Yoshitaka Ichiyanagi, President

For Cygni Co., Ltd., the executive team now features:

• - Katsuaki Hara, President
• - Naoki Ishikawa, Director
• - Yoshitaka Ichiyanagi, Director
• - Tetsuya Enari, Director
• - Teruhiro Yamazaki, Auditor

About Cygni Co., Ltd.

Founded in April 2006, Cygni Co., Ltd. specializes in providing critical medical supplies to healthcare institutions, including animal hospitals and welfare facilities. Their offerings also extend to pet shops and pet owners, supplying a range of pet products. Cygni is to continue its operations without any rebranding following the acquisition.
Visit Cygni's website

About MP Agro Co., Ltd.

MP Agro Co., Ltd., established in April 2010, plays a vital role in the pharmaceuticals sector, dealing with veterinary medicines and healthcare products. The company operates from its facility in Kitahiroshima and has positioned itself as a leader in developing agricultural and medical solutions. Their portfolio includes a wide array of products under categories like pharmaceuticals, agricultural chemicals, and animal nutrition.
Explore MP Agro

Parent Company Overview

Medipal Holdings Corporation, the parent company of MP Agro, was established in May 1923. Its headquarters are located in Chuo-ku, Tokyo, where it engages in managing a diverse array of subsidiaries focused on healthcare products, including human prescription drugs and animal health solutions. Medipal plays a crucial role in the broader strategic direction of its subsidiaries, facilitating healthcare advances and supporting business development in the pharmaceutical sector.
Discover more about Medipal

Conclusion

The acquisition of Cygni Holdings marks a pivotal chapter for MP Agro as it seeks to enhance its footprint in the animal health market. With continued commitment to providing necessary medical supplies and support services, both companies are poised to thrive in their respective sectors. As they move forward, the focus remains on the growth potential that this acquisition presents, ensuring a synergistic approach to business and service delivery.